525 related articles for article (PubMed ID: 20121479)
21. Proteomic analysis of bone cancer: a review of current and future developments.
Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
[TBL] [Abstract][Full Text] [Related]
22. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.
Drukier AK; Ossetrova N; Schors E; Krasik G; Grigoriev I; Koenig C; Sulkowski M; Holcman J; Brown LR; Tomaszewski JE; Schnall MD; Sainsbury R; Lokshin AE; Godovac-Zimmermann J
J Proteome Res; 2006 Aug; 5(8):1906-15. PubMed ID: 16889412
[TBL] [Abstract][Full Text] [Related]
23. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
[TBL] [Abstract][Full Text] [Related]
24. [Novel tumor marker discovery of gastrointestinal cancers using various proteomic approaches].
Tomonaga T; Nomura F
Rinsho Byori; 2007 Jan; 55(1):63-8. PubMed ID: 17319493
[TBL] [Abstract][Full Text] [Related]
25. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
26. [New biomarkers for the prostate cancer].
Ishii G; Kimura T; Kuruma H; Egawa S
Nihon Rinsho; 2012 May; 70(5):828-32. PubMed ID: 22620008
[TBL] [Abstract][Full Text] [Related]
27. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
Davis MA; Hanash S
Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
[TBL] [Abstract][Full Text] [Related]
28. Serum markers for prostate cancer: a rational approach to the literature.
Steuber T; O'Brien MF; Lilja H
Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
[TBL] [Abstract][Full Text] [Related]
29. Other biomarkers for detecting prostate cancer.
Nogueira L; Corradi R; Eastham JA
BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175
[TBL] [Abstract][Full Text] [Related]
30. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
31. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
Peng XQ; Wang F; Geng X; Zhang WM
Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
[TBL] [Abstract][Full Text] [Related]
32. Blood biomarkers for prostate cancer detection and prognosis.
Shariat SF; Karam JA; Roehrborn CG
Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
[TBL] [Abstract][Full Text] [Related]
33. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
Sørensen KD; Ørntoft TF
Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
[TBL] [Abstract][Full Text] [Related]
34. 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.
Byrne JC; Downes MR; O'Donoghue N; O'Keane C; O'Neill A; Fan Y; Fitzpatrick JM; Dunn M; Watson RW
J Proteome Res; 2009 Feb; 8(2):942-57. PubMed ID: 19093873
[TBL] [Abstract][Full Text] [Related]
35. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
36. New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
Shariat SF; Karam JA; Margulis V; Karakiewicz PI
BJU Int; 2008 Mar; 101(6):675-83. PubMed ID: 17941930
[TBL] [Abstract][Full Text] [Related]
37. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
38. New circulating biomarkers for prostate cancer.
Bensalah K; Lotan Y; Karam JA; Shariat SF
Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
[TBL] [Abstract][Full Text] [Related]
39. Proteomics of breast carcinoma.
Somiari RI; Somiari S; Russell S; Shriver CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
[TBL] [Abstract][Full Text] [Related]
40. Proteomics and biomarkers for ovarian cancer diagnosis.
Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
